AVITA Medical, Inc.
RCEL
$4.10
$0.194.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.29% | 3.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.29% | 3.24% | |||
| Cost of Revenue | 6.63% | 3.67% | |||
| Gross Profit | 9.90% | 3.14% | |||
| SG&A Expenses | -0.66% | -1.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.11% | 6.90% | |||
| Operating Income | 15.42% | -13.71% | |||
| Income Before Tax | 8.73% | 11.65% | |||
| Income Tax Expenses | 35.29% | -213.33% | |||
| Earnings from Continuing Operations | 8.69% | 11.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.69% | 11.88% | |||
| EBIT | 15.42% | -13.71% | |||
| EBITDA | 16.24% | -13.78% | |||
| EPS Basic | 9.18% | 17.64% | |||
| Normalized Basic EPS | 7.00% | 15.92% | |||
| EPS Diluted | 9.18% | 17.64% | |||
| Normalized Diluted EPS | 7.00% | 15.92% | |||
| Average Basic Shares Outstanding | 0.52% | 7.01% | |||
| Average Diluted Shares Outstanding | 0.52% | 7.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||